These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 27069016

  • 1. Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition.
    van den Brom RR, Abdulahad WH, Rutgers A, Kroesen BJ, Roozendaal C, de Groot DJ, Schröder CP, Hospers GA, Brouwer E.
    Rheumatology (Oxford); 2016 Jun; 55(6):1143-5. PubMed ID: 27069016
    [No Abstract] [Full Text] [Related]

  • 2. Antiphospholipid syndrome associated with combined immune checkpoint inhibitor therapy.
    Gupta A, Shah U, Khine H, Vandergriff T, Froehlich T.
    Melanoma Res; 2017 Apr; 27(2):171-173. PubMed ID: 28099367
    [No Abstract] [Full Text] [Related]

  • 3. Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma.
    Ugurel S, Kiecker F, Fröhling S, Wetter A, Bankfalvi A, Sucker A, Zimmer L, Livingstone E, Roesch A, Becker JC, Schadendorf D.
    Eur J Cancer; 2017 Sep; 83():142-145. PubMed ID: 28735071
    [No Abstract] [Full Text] [Related]

  • 4. Cardiotoxicity associated with immune checkpoint inhibitors in cutaneous oncology.
    Tabata MM, Choi S, Hirotsu K, Kwong B, Soleymani T.
    J Am Acad Dermatol; 2020 Apr; 82(4):986-994. PubMed ID: 31437546
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immune checkpoint inhibitor-induced granulomatosis with polyangiitis.
    Hung W, Cusnir I, Habib S, Smylie M, Solez K, Yacyshyn E.
    Rheumatology (Oxford); 2021 Jun 18; 60(6):e190-e191. PubMed ID: 33367837
    [No Abstract] [Full Text] [Related]

  • 8. Vogt-Koyanagi-Harada-like syndrome induced by immune checkpoint inhibitors in a patient with melanoma.
    Yoshida S, Shiraishi K, Mito T, Sayama K.
    Clin Exp Dermatol; 2020 Oct 18; 45(7):908-911. PubMed ID: 32394515
    [No Abstract] [Full Text] [Related]

  • 9. Autologous graft-versus-host disease with combined immune checkpoint blockade.
    Kofler L, Dréno B, Röcken M.
    Eur J Cancer; 2018 Sep 18; 101():275-277. PubMed ID: 30017386
    [No Abstract] [Full Text] [Related]

  • 10. Metastatic melanoma and immunotherapy-related uveitis: an incidence in Northern Ireland.
    Dolaghan MJ, Oladipo B, Cooke CA, McAvoy CE.
    Eye (Lond); 2019 Oct 18; 33(10):1670-1672. PubMed ID: 31114029
    [No Abstract] [Full Text] [Related]

  • 11. Cutaneous Eruption Secondary to Immunotherapy for Metastatic Melanoma Limited to Sites of Locoregional Melanoma Metastases: A Possible Variant of Locus Minoris Resistentiae.
    Donaldson M, Owen JL, Choi JN.
    JAMA Dermatol; 2018 Jul 01; 154(7):846-847. PubMed ID: 29800007
    [No Abstract] [Full Text] [Related]

  • 12. Immune checkpoint inhibitors-related orchitis.
    Brunet-Possenti F, Opsomer MA, Gomez L, Ouzaid I, Descamps V.
    Ann Oncol; 2017 Apr 01; 28(4):906-907. PubMed ID: 28039179
    [No Abstract] [Full Text] [Related]

  • 13. Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulins.
    Spänkuch I, Gassenmaier M, Tampouri I, Noor S, Forschner A, Garbe C, Amaral T.
    Eur J Cancer; 2017 Aug 01; 81():203-205. PubMed ID: 28641200
    [No Abstract] [Full Text] [Related]

  • 14. Type 1 diabetes in a melanoma patient treated with ipilimumab after nivolumab.
    Omodaka T, Kiniwa Y, Sato Y, Suwa M, Sato M, Yamaguchi T, Sato A, Miyake T, Okuyama R.
    J Dermatol; 2018 Oct 01; 45(10):e289-e290. PubMed ID: 29667767
    [No Abstract] [Full Text] [Related]

  • 15. Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors.
    Arangalage D, Delyon J, Lermuzeaux M, Ekpe K, Ederhy S, Pages C, Lebbé C.
    Ann Intern Med; 2017 Nov 07; 167(9):683-684. PubMed ID: 28869988
    [No Abstract] [Full Text] [Related]

  • 16. Autoimmune meningoencephalitis in a melanoma patient treated with ipilimumab.
    Choe JH, Andonian BJ, Kim GJ, Salama AK.
    Immunotherapy; 2016 Oct 07; 8(10):1163-7. PubMed ID: 27605066
    [No Abstract] [Full Text] [Related]

  • 17. Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab.
    Hantel A, Gabster B, Cheng JX, Golomb H, Gajewski TF.
    J Immunother Cancer; 2018 Jul 16; 6(1):73. PubMed ID: 30012206
    [Abstract] [Full Text] [Related]

  • 18. Balancing the Checkpoint: Managing Colitis Associated with Dual Checkpoint Inhibitors and High-Dose Aspirin.
    Hammami MB, Gill R, Thiruvengadam N, Oh DY, Beck K, Mahadevan U, Kattah MG.
    Dig Dis Sci; 2019 Mar 16; 64(3):685-688. PubMed ID: 30778872
    [No Abstract] [Full Text] [Related]

  • 19. Atrophic exocrine pancreatic insufficiency associated with anti-PD1 therapy.
    Hoadley A, Sandanayake N, Long GV.
    Ann Oncol; 2017 Feb 01; 28(2):434-435. PubMed ID: 27864215
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.